Press release
ADHD Therapeutics Market Evolving Opportunities by Top Industry Players Profiles - Concordia International Corp., Eli Lilly and Company, Highland Therapeutics Inc., Janssen Global Services LLC
ADHD Therapeutics Market - Scenario
Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder with a group of behavioral symptoms that include hyperactivity, inattentiveness and impulsiveness. The symptoms of ADHD begin in childhood and can continue through adolescence and adulthood.
As per the report published by Market Research Future (MRFR), the global ADHD therapeutics market is registered to grow steadily till the end of 2024.
GET PREMIUM SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/1573
ADHD Therapeutics Market - Key Players
Concordia International Corp.
Eli Lilly and Company
Highland Therapeutics Inc.
Janssen Global Services LLC
NEOS Therapeutics Inc.
Novartis AG
Noven Pharmaceuticals Inc.
Pfizer Inc.
Shire
Teva Pharmaceutical
ADHD Therapeutics Market - Segmentation
The global ADHD therapeutics market has been segmented on the basis of drug type and distribution channel. Based on drug type, the ADHD therapeutics market is segmented into stimulants and non-stimulants.
The stimulants segment is sub-segmented into amphetamine, methylphenidate, dextroamphetamine, lisdexamfetamine and others. The non-stimulants segment is sub-segmented into atomoxetine, bupropion, guanfacine and clonidine
Based on distribution channel, the ADHD therapeutics market is segmented into hospitals, clinics, pharmacies, research laboratories and others.
ADHD Therapeutics Market - Regional Analysis
Geographically, the Global ADHD Therapeutics Market is segmented into four major regions such as North America, Europe, Asia Pacific and the Middle East and Africa. The ADHD therapeutics market in the North America region accounts for the dominant share in the global ADHD therapeutics market owing to the increasing prevalence of ADHD in the children and high healthcare expenditure by the population in this region.
The ADHD therapeutics market in the Europe region is projecting significant growth owing to the increased research and development for the introduction of more effective drugs in this region. The Asia Pacific region is anticipated to grow at a notable pace in the coming years due to increased awareness regarding ADHD and its available treatments.
Whereas, the Middle East and Africa region is projecting steady growth in the global ADHD market owing to the low awareness and poor primary health care in the underdeveloped areas of this region.
ADHD Therapeutics Market - Drivers and Restraints
The symptoms of ADHD such as lack of attention, hyperactivity and impulsivity hamper proper functioning and development of an individual. Increasing awareness regarding neurodevelopmental disorders and easy availability of diagnostic guidelines over the internet is projected to boost the growth of the global ADHD therapeutics market.
OBTAIN PREMIUM RESEARCH REPORT DETAILS @ https://www.marketresearchfuture.com/reports/adhd-therapeutics-market-1573
Changing lifestyles and value systems along with the factors like genetic inheritance and premature birth are resulting to the rise in prevalence of ADHD among children in the age group of 4-17 years, which in turn is propelling the growth of the global ADHD therapeutics market.
Increasing availability of online platforms for therapists that assure anonymity of the patient is inclining more individuals towards undergoing therapeutic treatment for ADHD, which in turn is fueling the expansion of the global ADHD therapeutics market
However, underdiagnosis of ADHD due to the existence of comorbid conditions in children, lack of awareness and low availability of non-stimulant drugs to treat ADHD in various regions are likely to hamper the expansion of the global ADHD therapeutics market during the forecast period.
ADHD Therapeutics Market - Industry Updates
In August 2018, Ironshore Pharmaceuticals & Development, Inc., a subsidiary of Highland Therapeutics Inc., has received FDA approval for the New Drug Application for Jornay PM (methylphenidate) which was formerly known as HLD200 which is used for the treatment of ADHD in patients of the age six and older
In August 2018, FDA has issued a Complete Response Letter (CRL) to Sunovion Pharmaceutical asking for further clinical data to evaluate the efficacy of dasotraline, the ADHD drug.
Major Points form TOC for ADHD Therapeutics Market Research Report – Forecast to 2024
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global ADHD Therapeutics Market, By Type
Chapter 7. Global ADHD Therapeutics Market, By Treatment
Chapter 8 Global ADHD Therapeutics Market, By End User
Chapter 9. Global ADHD Therapeutics Market, By Region
Chapter 10 Company Landscape
Chapter 11 Company Profiles
Chapter 12 MRFR Conclusion
Chapter 13 Appendix
About Us:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release ADHD Therapeutics Market Evolving Opportunities by Top Industry Players Profiles - Concordia International Corp., Eli Lilly and Company, Highland Therapeutics Inc., Janssen Global Services LLC here
News-ID: 1490165 • Views: …
More Releases from Market Research Future
Ophthalmic Topical Therapeutics Market | Global Market Analysis Report - 2035
Ophthalmic Topical Therapeutics: Advancing Eye Care Through Targeted Treatment
Ophthalmic topical therapeutics have become a cornerstone in modern eye care, offering precise, localized treatment for a wide range of ocular conditions. Unlike systemic medications, which circulate throughout the body and may produce unintended side effects, topical therapies deliver active compounds directly to the eye, ensuring higher efficacy and a faster onset of action. This localized approach not only improves treatment outcomes…
Mental Health Apps Market Share, Size, Growth and Forecast to 2035
Mental Health Apps: Transforming the Way We Care for Our Minds
In recent years, mental health has gained increasing recognition as an essential component of overall well-being. Despite growing awareness, many individuals still face barriers to accessing mental health support, including stigma, cost, and geographic limitations. Mental health apps have emerged as a transformative solution, leveraging technology to provide accessible, personalized, and convenient mental health care for millions worldwide.
The Rise of…
Surgical Gloves Market Size, Share, Growth | CAGR of 4.95%
Surgical Gloves: A Critical Component of Modern Healthcare
Surgical gloves have become an indispensable element in modern healthcare, serving as a first line of defense against contamination, infection, and disease transmission. These gloves are not just protective gear-they are a symbol of safety, hygiene, and precision in medical practice. Their significance spans from routine hospital procedures to complex surgical interventions, highlighting their essential role in patient care and medical safety protocols.
The…
Asia Pacific CRO Market Size, Share & Growth Report by 2035
Asia Pacific CRO Market: Driving Innovation and Transformation in the Clinical Research Landscape
The Asia Pacific Contract Research Organization (CRO) market has been witnessing significant growth over the past decade, emerging as a pivotal hub for clinical research and drug development. With a growing population, increasing prevalence of chronic diseases, and rising investments in healthcare infrastructure, the region has become an attractive destination for pharmaceutical and biotechnology companies seeking cost-effective and…
More Releases for ADHD
Ezra Dewolfe Is the Go-To Expert at The ADHD Tools for Business Owners Held Back …
Image: https://www.globalnewslines.com/uploads/2025/10/797b50a8cfa02ca6e137f2168b3acf19.jpg
For entrepreneurs with ADHD, success often feels like a constant uphill battle. They are innovative, driven, and capable of building remarkable businesses, yet behind the scenes they are weighed down by missed deadlines, inconsistent execution, and burnout. Many blame themselves, thinking they simply lack discipline. In reality, the issue is not their character but the systems they have been taught to follow.
This is why so many entrepreneurs now turn…
My ADHD Life Journal by Meryl Bengtsson Offers a Fresh, Reflective Tool for ADHD …
Image: https://www.globalnewslines.com/uploads/2025/05/1748624322.jpg
In a world that often pushes individuals with ADHD to "try harder" or "focus more," author and ADHD life coach Meryl Bengtsson invites you to try something radically different. With her book and courses, she encourages you to listen to yourself. Her new book, My ADHD Life Journal: Building Self-Awareness [https://www.amazon.co.uk/My-ADHD-Life-Journal-Self-Awareness/dp/1967679673/], is a deeply personal and practical resource designed to guide individuals on a journey of gentle reflection and…
Rising Prevalence Of ADHD Spurs Growth In The Attention-Deficit Hyperactivity Di …
The Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market?
The market size for therapeutics related to attention deficit hyperactivity disorder (ADHD) has seen significant growth in…
ADHD Awareness Month: Dance Academy Founder Shares How Dance Helps Manage ADHD
This ADHD Awareness Month, Nix Academy - an up and coming dance and performing arts school - is highlighting the powerful impact of dance on managing ADHD symptoms. Founded by Nicky Rowe, who herself has ADHD, the academy has become a beacon of inclusivity, with around 40% of its students identifying as neurodiverse.
"Dance has been my lifeline in managing ADHD," says Nicky Rowe, Founder and Principal Teacher at Nix Academy.…
ADHD Answers from an ADHD Teen Brings Help to Parents, ADHD Boys
Sept. 4, 2006--Parents of boys with Attention Deficit Disorder (ADHD) have a new place to find answers to questions, problem-solving suggestions, and general help and support, both for their sons and for themselves. But the help comes from a source some will find surprising. \"Talk Back with Jack\" offers a forum for 11-year-old Jack Dixon to offer help and advice to ADHD boys and their parents as part of That\'s…
ADHD Myths — What If There Really Isn’t Anything Wrong with ADHD Children?
February 6, 2006 (Washington, D.C.) - An ADHD diagnosis can often signal a lifetime of struggles for children. But consider the case of Robbie Raffino.
Robbie used to rise every day like most eight-year-olds. He'd wipe the sleepiness from his eyes, throw on shorts and shirt that don't match and eat cereal while watching cartoons.
But the innocence ended there. He'd swallow his Ritalin, hop on the school bus and enter…
